Biologics

Andrew Cordover, MD, a spine surgeon with Andrews Sports Medicine & Orthopaedic Center in Birmingham, Ala., discusses the key technology trends for 2019.

Andrew Hecht, MD, chief of spine surgery at The Mount Sinai Health System in New York City, outlines the key trends and big opportunities in the spine device space moving forward.

Here are five orthopedic and sports medicine surgeons using Lipogems, an FDA-cleared technology that uses the body's own adipose tissue to help heal injuries.

Kuros Biosciences entered into a private label agreement with SeaSpine.

Robert Watkins Jr., MD, performed his first surgery with the Osseus Fusion Systems Aries-L technology, which is currently in alpha launch.

Ann Arbor-based Michigan Medicine researchers are working to improve the Masquelet orthopedic surgical technique, according to MHealth Lab.

Mark Miller, MD, is an orthopedic sports medicine surgeon and orthopedic surgery professor at the University of Virginia in Charlottesville.

Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair.

Seth L. Sherman, MD, enrolled and operated on four patients in a study of CartiHeal's Agili-C knee cartilage repair implant.  

Orthobiologics company Biogennix named Robert Bazier its new CFO.